Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman
J S
JS
Mehta
J
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D003327:Coronary Disease / Q000097:blood; D003645:Death, Sudden; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000502:physiology*; D012306:Risk; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013927:Thrombosis / Q000097:blood
D000319:Adrenergic beta-Antagonists; D001095:Arachidonic Acids; D011453:Prostaglandins; D016718:Arachidonic Acid; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone